Pfizer says mid-stage trial data support monthly dosing for GLP-1 therapy

Pfizer says mid-stage trial data support monthly dosing for GLP-1 therapy  Seeking Alpha

Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.